Long-Term Trends In Acute Bronchodilator Responses Over 4 Years In Patients With Mild/moderate To Very Severe COPD: Post-Hoc Analysis Of Data From The Uplift Trial

被引：0
|
作者：
Tashkin, D. P. [1 ]
Li, N. [1 ]
Kleerup, E. [1 ]
Halpin, D. [2 ]
Decramer, M. [3 ]
Celli, B. R. [4 ]
Elashoff, R. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Royal Devon & Exeter Hosp, Exeter, Devon, England
[3] Univ Leuven, Leuven, Belgium
[4] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5974
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long-term clinical trial data
    Kudrow, David
    Dafer, Rima
    Dodick, David W.
    Starling, Amaal
    Ailani, Jessica
    Dougherty, Carrie
    Kalidas, Kavita
    Zhang, Feng
    Jeswani, Rohini
    Patel, Nishil
    Khodavirdi, Ani C.
    HEADACHE, 2023, 63 (03): : 418 - 428
  • [32] Rapid and sustained improvements in itch and sleep with tralokinumab treatment in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis of pooled data from ECZTRA 1 and 2
    Simpson, E.
    Wollenberg, A.
    Soong, W.
    Mark, T.
    Kuznetsova, A.
    Abildgaard-Steffensen, L.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E132 - E133
  • [33] EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS AGED ≥75 YEARS: A POST HOC SUBGROUP ANALYSIS OF THE FINCH 4 LONG-TERM EXTENSION (LTE) STUDY
    Aletaha, D.
    Westhovens, R.
    Combe, B.
    Gottenberg, J. E.
    Buch, M. H.
    Caporali, R.
    Gomez-Puerta, J. A.
    Van Hoek, P.
    Rajendran, V.
    Stiers, P. J.
    Hendrikx, T.
    Burmester, G. R.
    Tanaka, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 612 - 613
  • [34] Long-Term Safety And Tolerability Of Indacaterol/glycopyrrolate In Moderate-To-Severe COPD Patients From The Us: A Subgroup Analysis From The Flight3 Study
    Ferguson, G. T.
    Schubert-Tennigkeit, A. A.
    Thach, C.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [35] Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial
    Pudipeddi, A.
    Lin, H.
    Paramsothy, S.
    Kariyawasam, V
    Paramsothy, R.
    Ghaly, S.
    Haifer, C.
    An, Y. K.
    Begun, J.
    Connor, S.
    Corte, C.
    Ward, M.
    De Cruz, P.
    Fung, C.
    Redmond, D.
    Chan, W.
    Mourad, F.
    Kermeen, M.
    Leong, R.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1453 - I1454
  • [36] Dupilumab Improves Post-bronchodilator Lung Function in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation: Data From the Phase 3 Boreas Trial
    Hanania, N. A.
    Bhatt, S. P.
    Rabe, K. F.
    Vogelmeier, C. F.
    Bafadhel, M.
    Christenson, S. A.
    Papi, A.
    Singh, D.
    Laws, E.
    Nivens, C.
    Bansal, A.
    Lu, X.
    Bauer, D.
    Maloney, J.
    Robinson, L. B.
    Abdulai, R. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [37] Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
    Deodhar, Atul
    Blauvelt, Andrew
    Lebwohl, Mark
    Feely, Meghan
    Kronbergs, Andris
    Eberhart, Nadezhda
    Zhu, Danting
    Inman, Elsa
    Grace, Elsie
    Holzkaemper, Thorsten
    Rahman, Proton
    Marzo-Ortega, Helena
    Papp, Kim A.
    Merola, Joseph F.
    Gottlieb, Alice B.
    Schwartzman, Sergio
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [38] Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
    Atul Deodhar
    Andrew Blauvelt
    Mark Lebwohl
    Meghan Feely
    Andris Kronbergs
    Nadezhda Eberhart
    Danting Zhu
    Elsa Inman
    Elsie Grace
    Thorsten Holzkaemper
    Proton Rahman
    Helena Marzo-Ortega
    Kim A. Papp
    Joseph F. Merola
    Alice B. Gottlieb
    Sergio Schwartzman
    Arthritis Research & Therapy, 26
  • [39] Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma
    Bagot, Martine
    Dalle, Stephane
    Sokol, Lubomir
    Tsianakas, Athansios
    Musiek, Amy
    Ortiz-Romero, Pablo L.
    Poligone, Brian
    Duvic, Madeleine
    Elmets, Craig
    Leoni, Mollie
    Dwyer, Karen
    Ito, Takahiro
    Herr, Fiona
    Kim, Youn H.
    DERMATOLOGIC THERAPY, 2022, 35 (08)
  • [40] Onset and Long-Term Maintenance of Optimal Itch Response in Adult Patients with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab: Post Hoc Analysis from Two Phase 3 Trials
    Staender, Sonja
    Yosipovitch, Gil
    Simpson, Eric L.
    Kim, Brian S.
    Kabashima, Kenji
    Thaci, Diamant
    Metz, Martin
    Chen, Zhen
    Hagen, Sandra
    Bastian, Mike
    ADVANCES IN THERAPY, 2025, : 1800 - 1810
12345